Breaking News

You are here » Indian-Commodity  :  Corporate  :  Kumaka Industries not to invest in Pinnacle Therapeutics

01-Aug2016

Kumaka Industries not to invest in Pinnacle Therapeutics

Kumaka Industries has decided not to go for investment in Pinnacle Therapeutics due to non availability of requisite finance. Earlier on July 06, 2015, the company decided to make investment of Rs 1 lakh in Equity shares of Pinnacle Therapeutics, so to make it wholly owned subsidiary of the Company.

The company is a leading manufacturer of pharmaceutical products. The company currently has its own manufacturing facility in GIDC Ankleshwar, Gujarat(India) to manufacturers Corticosteroids and its Salts. Over a period of time the company has understood the needs of its customers.


Related News

View all news

IOC to infuse Rs 1,200 crore in CNG distribution in Burdwan

Indian Oil Corporation (IOC) is planning to infuse Rs 1,200 crore over the next 6-7 years to create infrastructure of laying LPG pipeline and installing CNG stations in the two Burdwan districts of West......

IOC discovers seven geographical areas in Tamil Nadu: Report

Indian Oil Corporation (IOC) has reportedly discovered seven geographical areas (GAs) in ten districts of Tamil Nadu. The company will invest nearly Rs 2,100 crore in coming five years, in a bid to employ......

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Top News

View all news

Jumbo Finance gets shareholders' nod to increase borrowing limits up to Rs 30 crore

Jumbo Finance has received an approval to increase Borrowing Limits of the company up-to Rs 30 crore. The shareholders of the company at their meeting held on November 19, 2018, approved the same.Jumbo......

Alembic Pharma gets USFDA's nod for Vardenafil Hydrochloride Orally Disintegrating Tablets

Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Vardenafil Hydrochloride Orally Disintegrating Tablets,......

SRF expects total Rs 28 crore quantum of damage due to Cyclone GAJA

SRF is expecting a total Rs 28 crore quantum of damage caused, based on the initial assessment. The disruption of operations was due to Cyclone GAJA at the plant of Technical Textiles Business (Viralimalai)......